ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,152Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 224

$827K Total Retail Price of All Prescriptions

Rank: 2 out of 224

371 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 371 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 371 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,166 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
OMEPRAZOLE 404 280 1 3
SIMVASTATIN 362 250 2 1
GABAPENTIN 318 141 3 14
HYDROCODONE-ACETAMINOPHEN 222 84 S3 4 12
LISINOPRIL 210 173 5 2
LEVOTHYROXINE SODIUM 182 140 6 4
TRAMADOL HCL 182 69 6 18
FLUOXETINE HCL 176 100 8 37
METOPROLOL TARTRATE 165 144 9 7
FUROSEMIDE 157 138 10 5
QUETIAPINE FUMARATE 145 91 11 55
AMLODIPINE BESYLATE 140 132 12 8
METFORMIN HCL 135 63 13 9
METOPROLOL SUCCINATE 128 108 14 11
FENTANYL 124 59 S2 15 49
TRAZODONE HCL 121 78 16 20
CITALOPRAM HBR 120 97 17 15
OLANZAPINE 112 55 18 125
ATORVASTATIN CALCIUM 108 78 19 16
HYDROCHLOROTHIAZIDE 105 96 20 6
LYRICA 101 45 21 85
SERTRALINE HCL 98 56 22 17
MORPHINE SULFATE ER 94 44 S2 23 47
PREDNISONE 93 79 24 28
ZOLPIDEM TARTRATE 92 50 25 22
TOPIRAMATE 89 43 26 82
SUBOXONE 88 0 27 31
RISPERIDONE 87 66 28 50
WARFARIN SODIUM 78 44 29 10
IBUPROFEN 77 0 30 51
PEN NEEDLE 76 24 31 91
ADVAIR DISKUS 74 33 32 23
DIVALPROEX SODIUM 72 25 33 92
POTASSIUM CHLORIDE 70 65 34 24
PROAIR HFA 69 0 35 26
LANTUS 68 41 36 43
PANTOPRAZOLE SODIUM 68 55 36 27
DONEPEZIL HCL 68 67 36 36
CYMBALTA 68 11 36 44
OXYCODONE-ACETAMINOPHEN 66 44 S2 40 41
NYSTOP 66 55 40 100
IPRATROPIUM-ALBUTEROL 64 63 42 105
PAROXETINE HCL 63 38 43 52
CARBIDOPA-LEVODOPA 60 60 44 80
COMBIVENT 59 33 45 56
DICLOFENAC SODIUM 58 15 46 87
NEXIUM 57 31 47 34
RANITIDINE HCL 57 38 47 29
AMITRIPTYLINE HCL 54 35 R 49 78
LOVASTATIN 54 31 49 33
NAMENDA 54 41 49 65
CLOPIDOGREL 53 33 52 70
ALENDRONATE SODIUM 53 52 52 39
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 24 52 35
LEVETIRACETAM 52 48 55 169
TRIAMTERENE-HYDROCHLOROTHIAZID 52 32 55 169
CYCLOBENZAPRINE HCL 50 17 R 57 76
VENLAFAXINE HCL ER 50 20 57 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 27, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.